Initial Treatment With Bevacizumab in Choroidal Neovascularization Associated to High Myopia
Conditions
- Choroidal Subfoveal/Juxtafoveal Neovascularization in High Myopia
Interventions
- DRUG: Bevazizumab intravitreal injection
Sponsor
Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA